Back to top

Image: Bigstock

New Strong Buy Stocks for February 5th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Cabot Corporation (CBT - Free Report) : This leading global specialty chemicals and performance materials company has seen the Zacks Consensus Estimate for its current year earnings increasing 2.1% over the last 60 days.

Cabot Corporation Price and Consensus

 

Cabot Corporation Price and Consensus

Cabot Corporation price-consensus-chart | Cabot Corporation Quote

Costamare Inc. (CMRE - Free Report) : This company that operates as a containership owner chartering its vessels to liner companies has seen the Zacks Consensus Estimate for its current year earnings increasing 17.6% over the last 60 days.

Costamare Inc. Price and Consensus

 

Costamare Inc. Price and Consensus

Costamare Inc. price-consensus-chart | Costamare Inc. Quote

OneWater Marine Inc. (ONEW - Free Report) : This premium recreational boat retailer principally in the United States has seen the Zacks Consensus Estimate for its current year earnings increasing almost 7% over the last 60 days.

Exxon Mobil Corporation (XOM - Free Report) : This company that has the bellwether status in the energy space has seen the Zacks Consensus Estimate for its current year earnings increasing 56.6% over the last 60 days.

MidWestOne Financial Group, Inc. (MOFG - Free Report) : This company that provides commercial and retail banking products and services has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 3% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>